top of page
AdobeStock_170980846.jpeg

Connecting the dots

between patients and treatment.

+25 Years

of relevant experience in patient access

From Research to Patient Access

Reimbursed
Patient Access

We help biotech and pharmaceutical companies navigate pricing, reimbursement, and early access pathways.

We help biotech and pharmaceutical companies navigating pricing, reimbursement, and early access pathways to bring innovative therapies to BeNeLux patients in a sustainable way.

Vrouwelijke dokter
Man in wit overhemd
Zelfverzekerde vrouwelijke wetenschapper

Trusted by healtcare leaders Worldwide. 

100%

Executional Excellence

+25 yrs

Experience

120+

Successful Submissions

3 Countries

BeNeLux Client Partnerships

How We Support  Patient Access

Our expertise consists in navigating Pricing & Reimbursement, Guided Patient Access and Real-World Evidence

We demonstrate strategic engagement and executional excellence

with deep respect for the patient’s voice.

Bringing innovative medicines of pharmaceutical and biotech companies

to patients, sustainably and meaningfully

Guided Patient Access

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

Learn more

Pricing & Reimbursement

We build localised value stories, providing end-to-end support from early access to reimbursement.

Learn more

Real World Data

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition.

Learn more
BEB384F2-F3C4-4FD1-A418-7ACAB8BFA7B6_1_105_c.jpeg

The Axes Health team 

Dedicated to Patient Access

Our Mission

Pricing and reimbursement are complex

We help you navigate

Leveraging deep insights into local healthcare systems, we develop robust pricing and reimbursement strategies.

Cardiology

Nephrology

Haematology

Oncology

Respiratory

Neurology

Orphan Diseases

Dermatology

Therapeutic Domains

We  bring extensive experience across a broad range of therapeutic domains

01

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

Our Methodology

Integrated Market Access Solutions

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

04

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

02

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

03

Strategy Development

Defining the optimal pricing, access strategy and innovative contracting.

03

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

Why Choose Axes Health? 

  • Unmatched expertise in rare diseases.

  • Respected partner by health authorities.

  • Recognised executional excellence.

  • Deep respect for the patient’s voice.

C1DE6140-5817-41E4-8F67-FD135F9D35FC_1_105_c_edited.png

ABOUT US

SERVICES

HOME

Ready to optimise your access strategy? 

Contact us to discuss how we can support your patient access objectives

Ready to start your journey ?

Let us help you bring innovative therapies to the patients who need them most.

120+

SUCCESFUL 
SUBMISSIONS

Why Axes health ?

Empowering healthcare innovation through expert navigation.

25+

YEARS EXPERIENCE

Expert knowledge of the Belgian healthcare landscape and regulatory framework.

Featured Services

Learn more

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

Guided Patient Access

Learn more

We build localized value stories, providing end-to-end support from early access to reimbursement.

Pricing & Reimbursement

Learn more

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition"

Real-World Data

bottom of page